Literature DB >> 33355701

[Rheumatic diseases and neuropathic pain : Diagnosis and treatment].

J Lassen1, R Baron2.   

Abstract

Pain is a leading symptom in inflammatory rheumatic diseases. For a long time it has been assumed that this pain is of nociceptive origin; however, in about one fifth of all patients the pain remains despite successful anti-inflammatory treatment and is not typically described as nociceptive by those affected. Recent studies indicate that some patients with rheumatoid arthritis (RA) experience pain with a neuropathic pain component. The treatment of neuropathic pain with damage to the somatosensory system differs markedly from the treatment of nociceptive pain in which the pain processing system is intact. Thus, the recognition and, above all, the more precise differentiation of the pain symptoms of affected patients make a decisive contribution to a successful treatment. With the help of a few points in the history and a physical examination, the assumption of the diagnosis neuropathic pain can often be rejected or substantiated. Pain with a neuropathic component does not adequately respond to typical analgesics. Instead, the high efficacy of co-analgesics, such as anticonvulsants and antidepressants, has been repeatedly proven.

Entities:  

Keywords:  Analgesics; Anticonvulsants; Antidepressants; Arthritis; Somatosensory system

Mesh:

Substances:

Year:  2020        PMID: 33355701     DOI: 10.1007/s00393-020-00950-9

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  47 in total

Review 1.  Diagnosis and assessment of neuropathic pain through questionnaires.

Authors:  Nadine Attal; Didier Bouhassira; Ralf Baron
Journal:  Lancet Neurol       Date:  2018-03-26       Impact factor: 44.182

Review 2.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

3.  Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis.

Authors:  Sadaf Ashraf; Helen Wibberley; Paul Ian Mapp; Roger Hill; Deborah Wilson; David Andrew Walsh
Journal:  Ann Rheum Dis       Date:  2010-11-15       Impact factor: 19.103

4.  The nature of arthritis pain.

Authors:  R A Charter; A M Nehemkis; M A Keenan; D Person; P E Prete
Journal:  Br J Rheumatol       Date:  1985-02

Review 5.  Evidence that cytokines play a role in rheumatoid arthritis.

Authors:  Fionula M Brennan; Iain B McInnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

6.  Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.

Authors:  Amy S Chappell; Melissa J Ossanna; Hong Liu-Seifert; Smriti Iyengar; Vladimir Skljarevski; Linda Chunhong Li; Robert M Bennett; Harry Collins
Journal:  Pain       Date:  2009-07-21       Impact factor: 6.961

7.  The use of the McGill Pain Questionnaire in assessing arthritis pain.

Authors:  Carol S Burckhardt
Journal:  Pain       Date:  1984-07       Impact factor: 6.961

8.  Comparison of Pain Characteristics in Patients with Rheumatoid Arthritis and Systemic Sclerosis with Particular Reference to the Neuropathic Pain Component: Cross-Sectional Study.

Authors:  Gizem Cengiz; Kemal Erol; Kevser Gok; Salih Ozgocmen
Journal:  Med Princ Pract       Date:  2018-09-05       Impact factor: 1.927

Review 9.  Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Ele Ferrannini; Clodoveo Ferri; Poupak Fallahi
Journal:  Autoimmun Rev       Date:  2013-11-02       Impact factor: 9.754

10.  Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting.

Authors:  Saqa Ahmed; Tejal Magan; Mario Vargas; Abiola Harrison; Nidhi Sofat
Journal:  J Pain Res       Date:  2014-10-14       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.